PPT-The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction

Author : faustina-dinatale | Published Date : 2019-11-22

The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction Paull Rukavina RPh MTM provider Fairview Apple Valley and Highland Park Clinics OBJECTIVES

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "The Changing Landscape of Diabetes Thera..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: Transcript

The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction Paull Rukavina RPh MTM provider Fairview Apple Valley and Highland Park Clinics OBJECTIVES 1 Review ADAAACE Glycemic control Algorithms. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . . البورد العربي . كلية طب الموصل . . . . 2011. . . Prof. John Betteridge, MD. University College London. London, United Kingdom. Cardio. Diabetes . Master. . Class. Asian. . chapter. January. 28-30 2011, . Shanghai. Slide lecture prepared and held by:. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. Optimizing . patient care. William Cromwell, MD, FAHA, FNLA. Chief Medical Officer – LipoScience, Inc.. Chief – Lipoprotein and Metabolic Disorders Institute. Adjunct Associate Professor – Wake Forest University School of Medicine. and Glycemic Treatment Options. Rocky . Mountain/ACP. Internal . Medicine Conference. Banff. , AB. November 22, 2012. David C.W. Lau, MD, PhD, FRCPC. Depts. of Medicine. , . Biochem. . . & . Molec. J. Vassallo . (Malta). 15. th. MGSD Congress. 27-29 April, 2017. Organized by. Question. Do . you consider tight glycemic control . a. . priority . in management of type 2 diabetes. ?”. YES. Cyrus Desouza, MD. October 22, 2017. Why?. 1A. Evaluate the effect of vitamin D supplementation on incident CVD in people with . pre-diabetes.. 1B. . Establish CVD . risk in people with . pre-diabetes, defined by the modern ADA criteria.. www.onlinecjc.com. ). . If your reuse request qualifies as medical institution internal education, you may reuse the material under the following conditions:. You . must cite the Canadian Journal of Cardiology and the Canadian . MAHTAB NIROOMAND M.D.. Assistant professor of Endocrinology. SBUMS. Tehran 1391/11/19. . Out-line . Pathophysiology. and types of dyslipidemia in diabetic patients. Benefits of lipid- lowering therapy. David J Albrecht D.O.. Heart & Vascular 2018 Winter Conference. Cardiovascular risk . m. odification in relation to current diabetes management . therapies. Case study highlighting the therapeutic decisions . 2018 ADA GUIDELINES. Dr. . Sanjana. Bhagwat. Moderator : Dr. S. . Jotkar. Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Lipid Management in Patients with Endocrine. Disorders. An Endocrine Society Clinical Practice. Guideline. AGENDA. Screening and cardiovascular disease risk. Assessment . Type 2 diabetes mellitus . Type 1 diabetes mellitus . Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. Farzad. . Hadaegh. , MD, . Professor of Internal Medicine & Endocrinology. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences .

Download Document

Here is the link to download the presentation.
"The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.